SMAD2 and hepatocellular carcinoma: GP73 is reported to enhance Smad2/3 phosphorylation via activation of TGF-β1 and promote EMT via upregulation of EMT marker expression while SB431542 specifically inhibits Smad2/3 phosphorylation and reverses EMT in HCC [168].